PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, brain disorder, brainstem cancer, central nervous system cancer, central nervous system disorder, diffuse intrinsic pontine glioma, epithelial neoplasm, glioma, malignant glioma, medulloblastoma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2026-08-24		NCT05096481

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Duke University	446
Nationwide Children's Hospital	97

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
C.S. Mott Children's Hospital	Ann Arbor	United States	14
Children's Hospital Colorado	Aurora	United States	312
Children's Hospital of Philadelphia	Philadelphia	United States	434
Children's National Medical Center	Washington D.C.	United States	177
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Dana-Farber Cancer Institute	Boston	United States	626
Duke Cancer Center	Durham	United States	44
Nationwide Children's Hospital	Columbus	United States	309
Nicklaus Children's Hospital	Miami	United States	112
Seattle Children's Hospital	Seattle	United States	281
St. Louis Children's Hospital	St Louis	United States	30
Texas Children's Hospital	Houston	United States	187